Target-matched therapies in patients with advanced cervical cancers harboring PIK3CA mutations and/or PTEN loss.

被引：0
|
作者：
Hou, Ming-Mo [1 ]
Liu, Xiaochun [1 ]
Piha-Paul, Sarina A. [1 ]
Janku, Filip [1 ]
Wheler, Jennifer [1 ]
Naing, Aung [1 ]
Bodurka, Diane [1 ]
Schmeler, Kathleen [1 ]
Lu, Karen [1 ]
Zinner, Ralph [1 ]
Hong, David [1 ]
Meric-Bernstam, Funda [1 ]
Kurzrock, Razelle [2 ]
Fu, Siqing [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] UC San Diego Moores Canc Ctr, La Jolla, CA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-B191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B191
引用
收藏
页数：1
相关论文
共 50 条
  • [11] PIK3CA: a Target or a Marker in Breast Cancers
    Dieci M.V.
    Guarneri V.
    Current Breast Cancer Reports, 2015, 7 (3) : 161 - 169
  • [12] PIK3CA Mutations in Advanced Ovarian Carcinomas
    Wang, Yun
    Helland, Aslaug
    Holm, Ruth
    Kristensen, Gunnar B.
    Borresen-Dale, Anne-Lise
    HUMAN MUTATION, 2005, 25 (03) : 322
  • [13] EVALUATION OF THE PREDICTIVE VALUE OF PIK3CA MUTATIONS AND PTEN LOSS IN THE EFFICACY OF TRASTUZUMAB THERAPY
    Razis, E.
    Xanthakis, I.
    Kotoula, V.
    Bobos, M.
    Pentheroudakis, G.
    Pectasides, D.
    Makatsoris, T.
    Linardou, H.
    Kalogeras, K. T.
    Fountzilas, G.
    ANNALS OF ONCOLOGY, 2010, 21 : 100 - 100
  • [14] Mutations of the PIK3CA gene in hereditary colorectal cancers
    Miyaki, Michiko
    Iijima, Takeru
    Yamaguchi, Tatsuro
    Takahashi, Keiichi
    Matsmnoto, Hiroshi
    Yasutome, Michiya
    Funata, Nobuaki
    Mori, Takeo
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (07) : 1627 - 1630
  • [15] Oncogenic PIK3CA mutations in colorectal cancers and polyps
    Whitehall, Vicki L. J.
    Rickman, Celestine
    Bond, Catherine E.
    Ramsnes, Ingunn
    Greco, Sonia A.
    Umapathy, Aarti
    McKeone, Diane
    Faleiro, Rebecca J.
    Buttenshaw, Ron L.
    Worthley, Daniel L.
    Nayler, Sam
    Zhao, Zhen Zhen
    Montgomery, Grant W.
    Mallitt, Kylie-Ann
    Jass, Jeremy R.
    Matsubara, Nagahide
    Notohara, Kenji
    Ishii, Tatsuhiro
    Leggett, Barbara A.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) : 813 - 820
  • [16] PIK3CA and PTEN mutations as drivers of osimertinib resistance in patients with NSCLC.
    Grazini, Ursula
    O'Neill, Daniel J.
    Martin, Matthew
    Xu, Chintia
    Floch, Nicolas
    Smith, Paul D.
    Cuomo, Emanuela
    CANCER RESEARCH, 2022, 82 (12)
  • [17] KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
    De Roock, Wendy
    De Vriendt, Veerle
    Normanno, Nicola
    Ciardiello, Fortunato
    Tejpar, Sabine
    LANCET ONCOLOGY, 2011, 12 (06): : 594 - 603
  • [18] Recurrent inflammatory myofibroblastic tumors harboring PIK3CA and KIT mutations
    Li, Cheng-Fang
    Liu, Chun-Xia
    Li, Bing-Cheng
    Shen, Yao-Yuan
    Cui, Xiao-Bin
    Liu, Wei
    Dong, Hong-Chao
    Pang, Li-Juan
    Liang, Wei-Hua
    Li, Feng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (07): : 3673 - 3683
  • [19] Loss of PTEN expression, PIK3CA mutations, and breast cancer survival in the Nurses' health studies
    Wang, Tengteng
    Heng, Yujing J.
    Baker, Gabrielle M.
    Bret-Mounet, Vanessa C.
    Hankinson, Susan E.
    Holmes, Michelle D.
    Chen, Wendy Y.
    Willett, Walter C.
    Rosner, Bernard A.
    Tamimi, Rulla M.
    Eliassen, A. Heather
    CANCER RESEARCH, 2022, 82 (04)
  • [20] Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases
    Palimaru, Irina
    Brugmann, Anja
    Wium-Andersen, Marie Kim
    Nexo, Ebba
    Sorensen, Boe Sandahl
    SPRINGERPLUS, 2013, 2 : 1 - 7
12345